v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Balance at beginning of period (in shares) at Jan. 01, 2022   81,405        
Balance at beginning of period at Jan. 01, 2022 $ 925,980 $ 838 $ 750,478 $ (1,940) $ 278,395 $ (101,791)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   289        
Issuance of common stock 1,369 $ 3 1,366      
Stock based compensation $ 3,692   3,692      
Purchase of treasury stock (in shares) (200) (272)        
Purchase of treasury stock $ (10,649)         (10,649)
Settlement of 2025 Notes (1)   (1)      
Unrealized gain on hedge instruments, net of tax 188     188    
Net income 30,147       30,147  
Balance at end of period (in shares) at Apr. 02, 2022   81,422        
Balance at end of period at Apr. 02, 2022 $ 950,726 $ 841 755,535 (1,752) 308,542 (112,440)
Balance at beginning of period (in shares) at Dec. 31, 2022 78,992 78,992        
Balance at beginning of period at Dec. 31, 2022 $ 901,113 $ 842 767,112 (1,179) 320,517 (186,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   282        
Issuance of common stock 493 $ 3 490      
Stock based compensation $ 4,271   4,271      
Purchase of treasury stock (in shares) (1,100) (1,189)        
Purchase of treasury stock $ (27,609)         (27,609)
Settlement of 2025 Notes 0   0      
Unrealized gain on hedge instruments, net of tax 188     188    
Net income $ 18,270       18,270  
Balance at end of period (in shares) at Apr. 01, 2023 78,085 78,085        
Balance at end of period at Apr. 01, 2023 $ 896,726 $ 845 $ 771,873 $ (991) $ 338,787 $ (213,788)